Role of FDG PET/CT in imaging of renal lesions.
Focal incidental renal lesions are commonly encountered on positron emission tomography (PET)/computed tomography (CT) imaging. The vast majority of these lesions are benign. However, the interpretation of renal lesions can be problematic if the imaging criteria of simple cysts are not met. Limited literature exists on the characterisation of renal masses with metabolic imaging. The purpose of this article is to focus on the imaging features of benign and malignant renal masses with PET/CT. The lesions discussed include renal cyst, angiomyolipoma, oncocytoma, renal cell carcinoma, renal metastases and other infiltrating neoplastic processes affecting the kidney. Both the anatomical and metabolic features which characterise these benign and malignant entities are described. We emphasise the importance of viewing the CT component to identify the typical morphological features and discuss how to best use hybrid imaging for management of renal lesions. Metabolic imaging has a promising role in the imaging of renal lesions and can help prevent unnecessary biopsies and ensure optimal management of suspicious lesions.
Kochhar
R
R
Department of Radiology, The Christie, NHS Foundation Trust, Manchester, UK.
Brown
R K
RK
Wong
C O
CO
Dunnick
N R
NR
Frey
K A
KA
Manoharan
P
P
D018249:Adenoma, Oxyphilic / Q000175:diagnosis; D018207:Angiomyolipoma / Q000175:diagnosis; D002292:Carcinoma, Renal Cell / Q000175:diagnosis*; D003560:Cysts / Q000175:diagnosis; D019788:Fluorodeoxyglucose F18; D006801:Humans; D033162:Incidental Findings; D007668:Kidney / Q000000981:diagnostic imaging; D007674:Kidney Diseases / Q000175:diagnosis; D007680:Kidney Neoplasms / Q000175:diagnosis*; D007938:Leukemia / Q000175:diagnosis; D008223:Lymphoma / Q000175:diagnosis; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed / Q000379:methods*
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18